Morgan Stanley’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $21.2K | Sell |
|
|||||
|
2024
Q1 | $19.4K | Sell |
|
|||||
|
2023
Q4 | $37.6K | Buy |
|
|||||
|
2023
Q3 | $23.3K | Sell |
|
|||||
|
2023
Q2 | $257K | Buy |
|
|||||
|
2023
Q1 | $90.3K | Buy |
|
|||||
|
2022
Q4 | $66.6K | Buy |
|
|||||
|
2022
Q3 | $109K | Sell |
|
|||||
|
2022
Q2 | $429K | Sell |
|
|||||
|
2022
Q1 | $1.63M | Buy |
|
|||||
|
2021
Q4 | $553K | Buy |
|
|||||
|
2021
Q3 | $515K | Sell |
|
|||||
|
2021
Q2 | $926K | Sell |
|
|||||
|
2021
Q1 | $886K | Buy |
|
|||||
|
2020
Q4 | $750K | Buy |
|
|||||
|
2020
Q3 | $354K | Sell |
|
|||||
|
2020
Q2 | $831K | Buy |
|
|||||
|
2020
Q1 | $21K | Sell |
|
|||||
|
2019
Q4 | $300K | Buy |
|
|||||
|
2019
Q3 | $19K | Buy |
|
|||||
|
2019
Q2 | $18K | Buy |
|
|||||
|
2019
Q1 | $28K | Sell |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $39K | Sell |
|
|||||
|
2018
Q2 | $611K | Buy |
|
|||||
|
2018
Q1 | $357K | Buy |
|
|||||
|
2017
Q4 | $408K | Buy |
|
|||||
|
2017
Q3 | $194K | Buy |
|
|||||
|
2017
Q2 | $184K | Sell |
|
|||||
|
2017
Q1 | $344K | Buy |
|
|||||
|
2016
Q4 | $1K | Hold |
|
|||||
|
2016
Q3 | $1K | Hold |
|
|||||
|
2016
Q2 | $1K | Sell |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $3K | Sell |
|
|||||
|
2015
Q3 | $6K | Buy |
|
|||||
|
2015
Q2 | $3K | Buy |
|
|||||
|
2015
Q1 | $3K | Hold |
|
|||||
|
2014
Q4 | $3K | Hold |
|
|||||
|
2014
Q3 | $3K | Buy |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Hold |
|